Switzerland· 63240002
Noxafil 100 mg, magensaftresistente Tablette
A posaconazole product containing posaconazolum, registered in Switzerland by MSD Merck Sharp & Dohme AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 18 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Posaconazole is registered in 18 of 19 countries.
Countries holding a registration under ATC J02AC04 (posaconazole), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 10 of them publish a price we can compare per daily dose
Posaconazole · ATC J02AC04
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of posaconazole costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), the median price runs from $6.09 in United States to $82.67 in Italy — a ×14 gap.
- Switzerland: $74.94 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Posaconazole · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- IT Italy$82.67
- CH Switzerland$74.94
- US United States$6.09 (acquisition cost)
The record
At a glance
Swissmedic (Switzerland)- Active substance
- posaconazolum
- Manufacturer
- MSD Merck Sharp & Dohme AG
- Country
- Switzerland (CH)
- ATC code
- J02AC04
- ATC class
- Posaconazole
- Defined daily dose
- 0.3 g, O
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin768063240002296 StkCHF 2477.85
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
415 interactions on record for posaconazole.
Graded by severity as the source publishes them — 143 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Posaconazole · interactions on record
415 records
- 143 severe
- 219 moderate
- 7 minor
- 27 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- NaloxegolA06AH03severe
19 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Posaconazole in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaGUDIVINEgis Pharmaceuticals PLC, Budapešť
- United StatesPosaconazoleNorthStar RxLLC
- United KingdomNoxafil 100mg gastro-resistant tabletsMerck Sharp & Dohme (UK) Ltd
- NetherlandsNoxafil 100 mg maagsapresistente tablettenMerck Sharp & Dohme B.V.
- BelgiumNoxafil 100 mgMerck Sharp & Dohme
- SpainNOXAFIL 100 MG COMPRIMIDOS GASTRORRESISTENTESMerck Sharp & Dohme B.V.
- ItalyNOXAFILMERCK SHARP & DOHME BV
- SwedenNoxafil 100 mg EnterotablettMerck Sharp & Dohme BV
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Posaconazol Altan, Posaconazol Ratiopharm
- Belgium · Posaconazol Ab, Posaconazol Sandoz
- Czechia · Gudivin, Posaconazole Accord
- Germany · Ossmiq, Posaconazol
- Denmark · Posaconazol Stada, Posaconazol Teva B.V.
- Estonia · Ossmiq, Posaconazol
- Spain · Posaconazol, Posaconazol Abdi
- Finland · Posaconazol Vivanta, Posaconazole
- France · Posaconazole Accord, Posaconazole Altan
- United Kingdom (Northern Ireland) · Posaconazol Msn Laboratories, Posaconazole
- Greece · Posaconazole Genepharm, Posaconazole Stada
- Croatia · Posakonazol Abdi, Posakonazol Msn
- Hungary · Gudivin, Posaconazol Accord
- Ireland · Posaconazole, Posaconazole Teva
- Iceland · Noxafil, Posaconazole Accord
- Italy · Posaconazole Eg Stada, Posaconazole Mylan
- Liechtenstein · Noxafil, Posaconazole Accord
- Lithuania · Posaconazole Stada
- Latvia · Posaconazole Stada
- Malta · Posaconazole, Posaconazole Anfarm
- Netherlands · Posaconazol 100 Mg, Posaconazol Abdi
- Norway · Noxafil, Posaconazole Accord
- Poland · Posaconazole Accord, Posaconazole Aurovitas
- Portugal · Posaconazol Almovar, Posaconazol Anfarm
- Romania · Posaconazol, Posaconazol Accord
- Sweden · Posaconazole, Posaconazole Amarox
- Slovenia · Posaconazol Msn, Posakonazol Stada
- Slovakia · Posaconazol Msn, Posaconazole Msn
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8b92ee89-253f-467c-9a8f-36a7a44cdac8 GET /v1/drugs/8b92ee89-253f-467c-9a8f-36a7a44cdac8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "posaconazolum 100 mg",
"valid_from": "2015-05-01",
"limitations": "[{\"description\":\"Die Prophylaxe bei Hochrisikopatienten (siehe 1a und 1b) darf nur von qualifizierten Zentren verordnet werden.<br>\\n1a. Zur Prophylaxe von invasiven Mykosen (insbesondere Aspergillose) bei neutropenischen Patienten mit akuter myeloischer Leukämie oder myelodysplastischem Syndrom, die eine zytotoxische Chemotherapie erhielten.<br>\\n1b. Zur Prophylaxe von invasiven Mykosen (insbesondere Aspergillose) bei Patienten mit Graft versus Host Disease (Transplantat-gegen-Empfänger-Reaktion).<br>\\n2. Fusariose bei Patienten, deren Erkrankung therapieresistent ist gegenüber Amphotericin B bzw. bei Unverträglichkeit von Amphotericin B (2nd line).\\n3. Chromoblastomykose und Myzetom bei Patienten, deren Erkrankung therapieresistent ist gegenüber Itraconazol bzw. bei Unverträglichkeit von Itraconazol (2nd line).<br>\\n4. Kokzidioidomykose bei Patienten, deren Erkrankung therapieresistent ist gegenüber Amphotericin B, Itraconazol oder Fluconazol bzw. bei Unverträglichkeit dieser Arzneimittel (2nd line).<br>\\n<br>\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2022-12-01\"}]",
"galenic_form": "Tabl magensaftres 100 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2015-05-01",
"self_retention_pct": 10
}See everything about posaconazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.